Maruti Suzuki India Ltd. announces a new order win

Maruti Suzuki's projected R&D expenditure as a percentage of revenue for FY26-27 and historical R&D expenditures for the preceding three fiscal years are not separately disclosed in the company's reported financial statements or the Annual Integrated Report for FY 2025-26.

While the company highlights a multipowertrain strategy covering electric vehicle and hybrid technologies, alongside record annual sales of 24.22 lakh vehicles and SUV portfolio expansion ^[1], specific research and development budget projections or historical R&D expense line items are not publicly reported in the available KPI data or filing disclosures. Consequently, a quantitative comparison between projected and historical R&D intensity cannot be established from the current disclosures.

Capital Allocation Strategy & Funding Mix

Maruti Suzuki has not explicitly disclosed a numerical target ratio (e.g., percentage split between equity and debt) for its announced growth initiatives in its disclosures ^[1]. However, the implied funding mix is 100% internal accruals and zero external debt, consistent with the company's long-standing zero-leverage capital structure ^[2].

The primary announced capital expenditure commitments include:

• Biogas Plants: Initial phase investment of Rs 561 Crores to set up four biogas plants ^[1].
• Manufacturing Capacity: Addition of 500,000 units of manufacturing capacity in FY 2026-27 ^[1].
• Product Portfolio Expansion: Introduction of 7 new SUV models over the next 5 to 6 years ^[1].

March 2026 Balance Sheet Alignment

As of the March 2026 balance sheet, Maruti Suzuki maintains a debt-free capital structure alongside a large treasury reserve. Pure Cash and Cash Equivalents stand at Rs 66.90 Crores on a consolidated basis ^[3] (Rs 63.30 Crores standalone ^[4]). However, this narrow cash figure is complemented by a large treasury reserve held in liquid investments.

Implication for Growth Initiatives

• Funding Alignment: Although pure cash and cash equivalents of Rs 66.90 Crores ^[3] cover only a portion of near-term capex commitments (such as the Rs 561 Crores biogas project ^[1]), Maruti Suzuki’s capital allocation strategy relies on its Rs 74,288.70 Crores investment treasury ^[6] and internal cash accruals.
• Capital Structure Safety: Because total current debt ^[10] and long-term debt ^[11] remain at Rs 0.00 Crores, the company retains significant flexibility to fund its multi-year capacity expansion and product development without taking on balance-sheet leverage or diluting return metrics.

Disclosure Limits

• Specific Capex Guidance: Detailed project-by-project cost outlay estimates for the 500,000-unit expansion and the 7-model SUV pipeline were not explicitly quantified beyond the initial phase Rs 561 Crores biogas allocation in the cited annual update ^[1], ^[1].